바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.63 No.5
Citation Share

Clinical Manifestations of Persistent Smear Positive and Culture Negative Sputum Tests 5 Months after 417First-line Anti-Tuberculous Chemotherapy

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.63 no.5, pp.417-422






& (2007). Clinical Manifestations of Persistent Smear Positive and Culture Negative Sputum Tests 5 Months after 417First-line Anti-Tuberculous Chemotherapy. Tuberculosis & Respiratory Diseases, 63(5), 417-422.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: It is not known with certainty whether patients with persistently positive sputum smear results who have also had negative sputum culture results require prolongation of treatment for tuberculosis in order to avoid an increased risk of eventual relapse. The purpose of the present study was to retrospectively describe the treatment characteristics and evaluate the appropriate duration of treatment in these patients. Methods: Sixty of 69 patients with sputum smear positive and culture negative tests at 5 months after first line anti-tuberculous chemotherapy from 2002 to 2003 were retrospectively analyzed. Exclusion criteria included incomplete treatment or resistance to rifampicin or two additional antibiotics, as determined by a drug susceptibility test (DST). Results: Smear conversion of the study subjects was observed after 8.3±2.3 months treatment, and the patients were culture negative after 2.0±0.8 months. The relapse rates of the study subjects were 3.8, 10.0, and 25.8% after 1, 2, and 5 years of anti-tuberculosis chemotherapy, respectively. The relapse rates were not significantly affected by a series of risk factors such as age, sex, presence of diabetes, a sputum culture examination after 2 months treatment, previous treatment history, chest radiograph, and duration of the treatment (p＞0.05). Conclusion: Regimen change is not required for patients with persistent smear positive but culture negative tests in the fifth month for first line antituberculous treatment. However, a further study will be needed to clarify the high relapse rate in this specific group of patients. (Tuberc Respir Dis 2007;63:417-422)

keywords
Pulmonary tuberculosis, Acid-fast bacilli, Relapse, Pulmonary tuberculosis, Acid-fast bacilli, Relapse

Reference

1.

(brjdischest1981;75) A controlled trial of six months chemotherapy in pulmonary tuberculosis results during chemotherapy,

2.

(2007) 2007 Tuberculosis, Seoul: Korea Center for Disease Control & Prevention

3.

(amrevrespirdis1984;129) Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis,

4.

(1999) The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis,

5.

(1996) Incidence and significance of acid fast bacilli in sputum smears at the end of antituberculous treatment,

6.

(2002) Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion,

7.

(nationaltuberculosisassociation;1961) National Tuberculosis Association of the USA Diagnostic standards and classification of tuberculosis,

8.

(1998) Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients,

9.

(2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis,

10.

(tubercrespirdis1987;34) Relapse rates within one year after the completion of treatment with short course chemotherapy for pulmonary tuberculosis under programme conditions,

11.

(2004) Toman's Tuberculosis: case detection, treatment, and monitoring - questions and answers, Geneva: World Health Organization

12.

(2007) Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk,

13.

(2005) Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis,

14.

(2002) Rifapentine and isoniazid in the continuation phase of a 6-month regimen,

15.

(2001) Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started? ,

16.

(2004) Treatment of isoniazid-resistant pulmonary tuberculosis,

17.

(2003) American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis,

18.

(2003) American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America treatment of tuberculosis,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy